Strength and Weaknesses of Maxim Pharmaceuticals, Inc.

This comprehensive SWOT profile of Maxim Pharmaceuticals, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company. 

Know more about : Maxim Pharmaceuticals, Inc.

Comprehensive SWOT profile of Orient Pharma Co., Ltd.

This comprehensive SWOT profile of Orient Pharma Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Orient Pharma Co., Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Know more about :  Orient Pharma Co., Ltd.

Comprehensive SWOT profile of Hanmi Pharm Co., Ltd.

The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of Hanmi Pharm Co., Ltd. and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

For more information about : Hanmi Pharm Co., Ltd.

Get Detailed Information About the Applied NeuroSolutions, Inc. Company

Applied NeuroSolutions, Inc. (APNS) is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of Alzheimer’s disease (AD). Its core technology is based on exclusive licensing agreement with Albert Einstein College of Medicine (AECOM), which covers all diagnostic and therapeutic applications in the field of neurodegenerative disease. The company strongly focuses on its research and development activities to develop new products and launch in the market sooner. Currently, APNS is working on both cerebrospinal fluid (CSF) based tests and serum based tests to detect AD at an early stage. The company is headquartered in Illinois, the US.

This comprehensive SWOT profile of Applied NeuroSolutions, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


For more information kindly visit :  Applied NeuroSolutions, Inc.

New Frontiers in Cell Line Development and Opportunities for Biosimilars

Conference Description

Key Speakers Include:-

Arun Bhatt, President, Clininvent Research 

R. H. Jani, Senior Vice President, Clinical R&D, Cadila

Purnima Sharma, Managing Director, Biotech Consortium India Limited BCIL

Annaswamy Vaidheesh, Vice President- Government affairs Asia Pacific, Johnson & Johnson

Bobby George, Asssitant Vice President and Head, Regulatory Affairs, Reliance Life Sciences

Dilip Pawar, Director and Head Clinical Development, Dr Reddys

Kaustubh Berde, Vice President & Head - International Formulations, Panacea Biotec

Yatin Gokarn, Narotam Sekhsaria Distinguished Professor of Chemical Engineering, Institute of Chemical Technology.

(Former Associate Director, Genentech (San Francisco)

Anurita Majumdar, Director - Medical & Regulatory - India & South Africa, Eli Lilly

Chirag Trivedi, Associate Director - Project Management & Strategic Initiatives, Sanofi-Aventis

Kedar Suvarnapathaki, Head - Regulatory Affair, Boehringer Ingelheim

Yasmin Shenoy, Director-Regulatory Affairs, Sanofi-Aventis

Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates

Plus Many More...

The recent establishment of regulatory guidelines for biosimilars in India is expected to add further momentum to the growth of the global biosimilars market. Increasing pressure from governments and insurers for greater biologic competition, there exists an incredible opportunity for biosimilar producers to capitalise on what is set to become the fastest growing sector of the pharmaceutical industry. Due to the limited clinical database at the time of approval of a biosimilar, vigorous pharmacovigilance is required. & Biosimilars are set to become an important part of the future medicines market.

To know more about conferences on : 

3rd Biosimilars Congregation 2013

Breathe Technologies, Inc. - Medical Equipment Company

Breathe Technologies, Inc. (Breathe Technologies) is a health-care solutions provider, based in the US. The company develops and manufactures the therapeutic respiratory systems. The respiratory systems are useful to patients of various respiratory illnesses such as emphysema, chronic bronchitis, cystic fibrosis, influenza, among other respiratory conditions that limit normal breathing. Its products include ultra lightweight, compact, wearable mobile ventilator system that helps during breathing problems and is useful for heart – patients. The company develops solutions for empowering healthcare providers and patients with reliable and accessible respiratory therapies that optimize breathing and mobility. Breathe Technologies is headquartered in San Ramon, California, the US.

Breathe Technologies, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. 

To know more about : Breathe Technologies, Inc

Smith & Nephew, Inc. - Medical Equipment - Deals and Alliances Profile

Smith & Nephew, Inc. is a medical device company. It carries out the development, manufacture and marketing of medical devices. The company manufactures orthopedic reconstruction and trauma, endoscopy, and advanced wound management equipment. It offers its products for surgeons and hospitals. The company is a subsidiary of Smith & Nephew Plc. Smith & Nephew, Inc is headquartered in Memphis, Tennessee, the US.

Smith & Nephew, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

To know more :  Smith & Nephew, Inc